Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000899923-23-000024
Filing Date
2023-04-12
Accepted
2023-04-12 16:08:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-2023proxyadditiona.htm DEFA14A 8478
2 instructions_p1.jpg GRAPHIC 116809
3 instructions_p2.jpg GRAPHIC 117458
  Complete submission text file 0000899923-23-000024.txt   332292
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 23815776
SIC: 2835 In Vitro & In Vivo Diagnostic Substances